Study aims and goal: The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance and functioning in participants with HD.
No. of study participants and sites: This phase II study aims to recruit participants from approximately 50 sites in Australia, Europe and North America.
For further information see the clinical trial registration.